Clinical Trial Update: Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating the efficacy and safety of ramelteon in subjects with mild to moderate Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Insomnia

Drugs mentioned

• Ramelteon (ramelteon)

Snippet

Sponsor: Takeda | Conditions: Chronic Insomnia | Phase 2 | Status: COMPLETED